Cardiotoxicity: all 269 studies
Page 2 of 3. Open to participants first (71), then studies with results posted, then the rest; newest registration first within each.
- Evaluation of Impedance Cardiography for Assessing Hemodynamic Shifts in Patients With LA-NSCLC During Treatment.Active, not recruitingNCT06277388
- Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer PatientsCompletedNCT06155331Phase 2
- Cancer Treatment Related Cardiovascular Toxicity: Comprehensive Myocardial and Vascular PhenotypingStatus unknownNCT06048458
- Stress Echocardiography to Identify Chemotherapy Induced Cardiotoxicity in Cancer Patients With Heart Failure RiskCompletedNCT05950399Not applicable
- Translating ECHOS2 Into an mHealth PlatformCompletedNCT05923242Not applicable
- Safety of Withdrawal of Pharmacological Treatment for Recovered HER2 Targeted Therapy Related Cardiac DysfunctionCompletedNCT05880160Not applicable
- Role of Statin Therapy in Prevention of Anthracycline-Induced CardiotoxicityStatus unknownNCT05792293Phase 2/3
- The Effects of Two Exercise Interventions on Breast Cancer Patients Undergoing Cardiotoxic ChemotherapiesCompletedNCT05786014Not applicable
- Prediction of Delayed Toxic Cardiomyopathy in ChildrenTerminatedNCT05781672Not applicable
- Cardiovascular Effects of Intrathecal Hyperbaric Prilocaine or Bupivacaine in Surgery Under Spinal AnesthesiaStatus unknownNCT05751148Not applicable
- Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Cisplatin Among Egyptian Non-small Cell Lung Cancer PatientsStatus unknownNCT05746598
- Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With AnthracyclinesStatus unknownNCT05728632Phase 3
- Clinical and Diagnostic Significance of Endothelial Dysfunction and Myocardial Contractility in Patients With AMLCompletedNCT05703126Not applicable
- Extensive CArdioVAscular Characterization and Follow-up of Patients Receiving Immune Checkpoint InhibitorsTerminatedNCT05699915Not applicable
- Cardiotoxicity Monitoring With Single-lead ElectrocardiogramCompletedNCT05676606Not applicable
- Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer PatientsStatus unknownNCT05595109Phase 2/3
- Cardiotoxicities in Patients Receiving BTKiWithdrawnNCT05521178
- Cardiovascular Diagnostic in Assessment of Risk HDS and HCT in Patients With Haemoblasts.CompletedNCT05508087Not applicable
- Early Diagnosis of Therapy-associated Cardiotoxicity Basing on PET/CT in LymphomaStatus unknownNCT05411250
- Imaging Versus Cardiac Biomarker Monitored HER2 Directed Therapy in Patients With Breast CancerActive, not recruitingNCT05406635Not applicable
- Cardiac Toxicity of Hypo Fractionated Radiotherapy in Left Breast CancerStatus unknownNCT05358093
- Assessment of Myocardial Injury in Patients Treated With Immune Checkpoint InhibitorsStatus unknownNCT05349058
- Possible Protective Effect of Rosuvastatin in Chemotherapy-induced Cardiotoxicity in HER2 Positive Breast Cancer PatientsCompletedNCT05338723Phase 3
- Identification of Novel Inflammation-related Biomarkers for Early Detection of Anthracycline-induced Cardiotoxicity in Breast Cancer PatientsStatus unknownNCT05298072
- Empagliflozin in the Prevention of Cardiotoxicity in Cancer Patients Undergoing Chemotherapy Based on AnthracyclinesActive, not recruitingNCT05271162Phase 3
- Bisoprolol Administration to Prevent Anthracycline-induced CardiotoxicityCompletedNCT05175066Phase 3
- Early Identification and Evaluation of Cyclophosphamide CardiotoxicityStatus unknownNCT05150080
- CAR T Cell Therapy Related Cardiovascular OutcomesCompletedNCT05130489
- Atherosclerosis in Chemotherapy-related CardiotoxicityCompletedNCT05118178
- Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Prostate CancerActive, not recruitingNCT05096338
- Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Breast CancerActive, not recruitingNCT05078190
- Cardiotoxicity of Targeted Therapy for HER-2 Positive Breast Cancer Patients at High AltitudeStatus unknownNCT05063643
- Exercise Prescription Guided by Heart Rate Variability in Breast Cancer PatientsStatus unknownNCT05040867Not applicable
- Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild CardiotoxicityActive, not recruitingNCT05036252
- Investigating the Long-term Cardiac Sequelae of Trastuzumab TherapyStatus unknownNCT05019365
- Effects of Anti-VEGF Targeted Drugs on Patients' Blood Pressure and Endothelial FunctionStatus unknownNCT04962438
- Risk Assessment Model of Trastuzumab-related Cardiotoxicity in Breast Cancer PatientsStatus unknownNCT04962425
- Evaluation of Heart Function in Breast Cancer Patients Using TrastuzumabStatus unknownNCT04961307
- Effects of Carvedilol on Cardiotoxicity in Cancer Patients Submitted to Anthracycline TherapyActive, not recruitingNCT04939883Phase 4
- Effect of Trimetazidine on Radiotherapy-induced Heart Damage.Status unknownNCT04939857Phase 2/3
- Evaluating 6-months of HER2-targeted Therapy in Patients With HER2 Positive Early-stage Breast Cancer That Achieve a Pathological Complete Response to Neoadjuvant Systemic TherapyActive, not recruitingNCT04928261Phase 4
- Multimodal Assesment of Acute Cardiac Toxicity Induced by Thoracic Radiotherapy in Cancer PatientsCompletedNCT04896242
- Early Detection of Patients at Risk of Developing Anthracycline Cardiotoxicity With TEP/CT -FDGActive, not recruitingNCT04892667Not applicable
- Smart Home Care of Cloud Base ECG on the Cardiotoxicity Prevention on the Cancer Patients.Status unknownNCT04885088
- Validation of Quantitative Myocardial Tissue Characterization Through Non-gated CTTerminatedNCT04880317Not applicable
- Mazankowski Alberta Heart Institute (MAHI) EchoGo Discovery 1 ProtocolStatus unknownNCT04877899
- Radiation-induced Cardiac Toxicity After Non-small Cell Lung Cancer RadiotherapyStatus unknownNCT04867564
- Late Anthracycline Induced Cardiotoxicity- Childhood Cancer SurvivorsCompletedNCT04852965
- Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive CarfilzomibTerminatedNCT04827563
- Early Detection of Cardiotoxicity From Systemic and Radiation Therapy in Breast Cancer PatientsCompletedNCT04790266
- Trimetazidine As a Potential Adjuvant Therapy in Acute Aluminum Phosphide Poisoning-induced CardiotoxicityStatus unknownNCT04702906Not applicable
- Radiotherapy for Thoracic and Breast Cancer and the Related Cardiotoxicity Following Treatment (RACCOON)Status unknownNCT04674501
- Can Flaxseed Prevent Broken Hearts in Women With Breast Cancer Study?Status unknownNCT04632407Not applicable
- The Harmonized Interventions to Maintain Health Via Appropriate Risk Factor Modification and Lifestyle Changes in Pediatric, Adolescent and Young Adult Cancer Survivors Pilot StudyCompletedNCT04598646Not applicable
- Effect of Anthracyclines and Cyclophosphamide on Cardiovascular ResponsesCompletedNCT04568161Not applicable
- Evaluation of Cardiotoxicity and Hypertension in Patients With Non Metastatic Castration Resistant Prostatic CarcinomaStatus unknownNCT04567875
- Early Diagnosis of Therapy-associated Cardiotoxicity Basing on Multi-tracer Multimodality PET/MRIStatus unknownNCT04555642
- Cardiac Effects From Radiation Therapy by MRICompletedNCT04486573Not applicable
- Aerobic Exercise is Cardio-protective in Hemato-oncological Disease and New-onset ChemotherapyActive, not recruitingNCT04476576Not applicable
- Exercise Response After Revalidation in Cancer PatientsStatus unknownNCT04461392Not applicable
- Evaluation of Myocardial Injury After Anthracycline Chemotherapy in Osteosarcoma Patients Using CMRStatus unknownNCT04461223
- Strain vs. Left Ventricular Ejection Fraction-based Cardiotoxicity Prevention in Breast CancerStatus unknownNCT04429633Not applicable
- Association Between Telomere Length and Cardiac DysfunctionCompletedNCT04409379
- Cardiotoxicity in Breast Cancer Patients Treated With Proton or Photon Radiotherapy: A RadComp Companion StudyCompletedNCT04361240
- Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated With Chemoradiation TherapyActive, not recruitingNCT04305613
- Cardiotoxicity of Aluminum Phosphide Poisoning; Tropinin and CKmb as Early BiomarkersStatus unknownNCT04191265
- Molecular Imaging of the Underlying Mechanism of Cardiotoxicity in Patients With Light Chain Amyloidosis Using PET/CTTerminatedNCT04105634Early Phase 1
- Effect of Angiotensin Converting Enzyme and Sacubitril Valsartan in Patients After Bone Marrow TransplantationStatus unknownNCT04092309Not applicable
- Observational Trial of Cardiotoxicity in Patients Undergoing Chemotherapy.Status unknownNCT04055636
- Effect of Physical Training in Patients With Heart Failure Caused by Chemotherapy for Cancer TreatmentStatus unknownNCT04047901Not applicable
- Early Detection of Cardiac Damage With CMR in Women With Breast CancerStatus unknownNCT04046315
- Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced CardiotoxicityTerminatedNCT04044872Early Phase 1
- Role of Aerobic Exercise to Modulate Cardiotoxicity in Long Term Cancer Survivors Exposed to Anthracycline TherapyCompletedNCT04036032
- Ivabradine to Prevent Anthracycline-induced CardiotoxicityStatus unknownNCT04030546Phase 3
- Cardiovascular Effects of CART Cell TherapyCompletedNCT04026737
- Cardiotoxicity in the ElderlyStatus unknownNCT03981588
- Exercise-based Cardiac Rehabilitation for the Prevention of Breast Cancer Chemotherapy-induced CardiotoxicityCompletedNCT03964142Not applicable
- Anthracycline Induced Cardiotoxicity - Early Detection by Combination of Diastolic Strain and T2-mappingCompletedNCT03940625Not applicable
- Vascular Cardiotoxicity of PonatinibStatus unknownNCT03930394
- Cancer Adverse Effects PReventIon With Care & Exercise: the CAPRICE StudyTerminatedNCT03850171Not applicable
- Attenuating Cancer Treatment-related Toxicity in Oncology Patients With a Tailored Physical Exercise ProgramCompletedNCT03787966Not applicable
- Cardiovascular Function in Acute LeukemiaCompletedNCT03760237
- Exercise to Prevent AnthraCycline-based Cardio-Toxicity Study 2.0 (EXACT2)Active, not recruitingNCT03748550Not applicable
- Ivabradine to Prevent Anthracycline-induced CardiotoxicityStatus unknownNCT03650205Not applicable
- Avoiding Cardiac Toxicity in Lung Cancer Patients Treated With Curative-intent RadiotherapyStatus unknownNCT03645317Not applicable
- Low-dose CT-based Method for Detection of Subclinical Anthracycline-induced CardiotoxicityCompletedNCT03553654Not applicable
- MyoStrain CMR for the Detection of CardiotoxicityCompletedNCT03543228
- Evaluation of Reporting of Cardio-vascular Adverse Events With Antineoplastic and Immunomodulating Agents (EROCA)CompletedNCT03530215
- Prevention of Chest Pain in Chemo-treated Cancer PatientsCompletedNCT03486340Not applicable
- Subclinical Cardio-toxicities Evaluation With Strain Rate Echocardiography After Chemotherapy and/or Mediastinal Radiotherapy in Patient With LymphomaCompletedNCT03480087
- Detecting Radiation-Induced Cardiac Toxicity After Non-Small Cell Lung Cancer RadiotherapyStatus unknownNCT03416972
- Prevention of Chemotherapy Induced Cardiotoxicity in Children With Bone Tumors and Acute Myeloid LeukemiaCompletedNCT03389724Phase 3
- Cardiac Magnetic Resonance for Early Detection of Chemotherapy or Radiation Therapy Induced Cardiotoxicity in Breast Cancer (CareBest)Status unknownNCT03301389
- Comparison of Cardiotoxicity Induced by Selective Estrogen REceptor Modulators and aNti-AromataseCompletedNCT03259711
- cARdiotoxicity Profile of aBIraTeRone in prostAte Cancer : a pharmacoviGilancE StudyCompletedNCT03243604
- The CAROLE (CArdiac Related Oncologic Late Effects) StudyCompletedNCT03235427
- CardioTOxicity Induced by andRogeNICS and Their Antagonists (TORNICS)CompletedNCT03193138
- Statins for the Primary Prevention of Heart Failure in Patients Receiving Anthracycline Pilot StudyStatus unknownNCT03186404Phase 2
- Remote Ischaemic Preconditioning in Childhood CancerCompletedNCT03166813Not applicable
- Novel Biomarkers and Echocardiography for Subclinical Cardiac Toxicity in Breast Cancer Patients Receiving AnthracyclinesStatus unknownNCT03155802